These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25252629)

  • 1. Isolation and development of bioluminescent reporter phages for bacterial dysentery.
    Schofield DA; Wray DJ; Molineux IJ
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):395-403. PubMed ID: 25252629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and characterization of Shiga toxin converting temperate phages carried by Shigella flexneri in Hispaniola.
    Fogolari M; Mavian C; Angeletti S; Salemi M; Lampel KA; Maurelli AT
    Infect Genet Evol; 2018 Nov; 65():321-328. PubMed ID: 30075254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri.
    McCloskey MC; Shaheen S; Rabago L; Hulverson MA; Choi R; Barrett LK; Arnold SLM
    Sci Rep; 2019 Sep; 9(1):13567. PubMed ID: 31537849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigellosis in Nepal: 13 years review of nationwide surveillance.
    Shakya G; Acharya J; Adhikari S; Rijal N
    J Health Popul Nutr; 2016 Nov; 35(1):36. PubMed ID: 27814742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid emergence of third-generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India.
    Bhattacharya D; Purushottaman SA; Bhattacharjee H; Thamizhmani R; Sudharama SD; Manimunda SP; Bharadwaj AP; Singhania M; Roy S
    Microb Drug Resist; 2011 Jun; 17(2):329-32. PubMed ID: 21352076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance.
    Bogaerts J; Verhaegen J; Munyabikali JP; Mukantabana B; Lemmens P; Vandeven J; Vandepitte J
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):165-71. PubMed ID: 9327243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011.
    Yang H; Chen G; Zhu Y; Liu Y; Cheng J; Hu L; Ye Y; Li J
    Ann Lab Med; 2013 Mar; 33(2):111-5. PubMed ID: 23482897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in-vitro study on a novel six-phage cocktail against multi-drug resistant-ESBL Shigella in aquatic environment.
    Shahin K; Zhang L; Bao H; Hedayatkhah A; Soleimani-Delfan A; Komijani M; He T; Barazandeh M; Mansoorianfar M; Bouzari M; Wang R
    Lett Appl Microbiol; 2021 Mar; 72(3):231-237. PubMed ID: 33070360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Shigella dysenteriae type 1 and Shigella flexneri in feces by immunomagnetic isolation and polymerase chain reaction.
    Islam D; Lindberg AA
    J Clin Microbiol; 1992 Nov; 30(11):2801-6. PubMed ID: 1452650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigellosis in Calcutta during 1990-1992: antibiotic susceptibility pattern and clinical features.
    Bhattacharya MK; Bhattacharya SK; Paul M; Dutta D; Dutta P; Kole H; De D; Ghosh AR; Das P; Nair GB
    J Diarrhoeal Dis Res; 1994 Jun; 12(2):121-4. PubMed ID: 7963341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shigellosis in children: a clinico-epidemiological comparison between Shigella dysenteriae type I and Shigella flexneri.
    Faruque AS; Teka T; Fuchs GJ
    Ann Trop Paediatr; 1998 Sep; 18(3):197-201. PubMed ID: 9924557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical & bacteriological profiles of shigellosis in Calcutta before & after an epidemic (1984-87).
    Dutta P; Dutta D; Bhattacharya SK; Sen D; Mitra U; Ghosh AR; Lahiri M; Deb BC
    Indian J Med Res; 1989 May; 89():132-7. PubMed ID: 2674001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Shigella dysenteriae type 1 and S. flexneri strains from surface waters in Bangladesh: comparative molecular analysis of environmental Shigella isolates versus clinical strains.
    Faruque SM; Khan R; Kamruzzaman M; Yamasaki S; Ahmad QS; Azim T; Nair GB; Takeda Y; Sack DA
    Appl Environ Microbiol; 2002 Aug; 68(8):3908-13. PubMed ID: 12147489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity and antibiotic resistance in Shigella dysenteriae and Shigella boydii strains isolated from children aged <5 years in Egypt.
    El-Gendy AM; Mansour A; Weiner MA; Pimentel G; Armstrong AW; Young SY; Elsayed N; Klena JD
    Epidemiol Infect; 2012 Feb; 140(2):299-310. PubMed ID: 21470441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shigellosis in children: a prospective hospital based study.
    Dutta P; Bhattacharya SK; Sen D; Bhattacharya MK; Mitra U; Rasaily R; Manna B; Mukherjee A; Pal SC
    Indian Pediatr; 1992 Sep; 29(9):1125-30. PubMed ID: 1452309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006).
    Sire JM; Macondo EA; Perrier-Gros-Claude JD; Siby T; Bahsoun I; Seck A; Garin B
    Jpn J Infect Dis; 2008 Jul; 61(4):307-9. PubMed ID: 18653976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization and genomic analysis of a novel lytic bacteriophage vB_SsoS-ISF002 infecting Shigella sonnei and Shigella flexneri.
    Shahin K; Bouzari M; Wang R
    J Med Microbiol; 2018 Mar; 67(3):376-386. PubMed ID: 29458535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
    Kotloff KL; Winickoff JP; Ivanoff B; Clemens JD; Swerdlow DL; Sansonetti PJ; Adak GK; Levine MM
    Bull World Health Organ; 1999; 77(8):651-66. PubMed ID: 10516787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.